Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
44
STE Quote, Financials, Valuation and Earnings
Last price:
$255.45
Seasonality move
:
2.04%
Day range:
$254.84 - $257.56
52-week range:
$200.98 - $268.60
Dividend yield:
0.94%
P/E ratio:
36.39x
P/S ratio:
4.43x
P/B ratio:
3.58x
Volume:
259.2K
Avg. volume:
643.2K
1-year change:
22.52%
Market cap:
$25.1B
Revenue:
$5.5B
EPS (TTM):
$7.03
Analysts' Opinion
-
Consensus RatingSTERIS Plc (Ireland) has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $281.63, STERIS Plc (Ireland) has an estimated upside of 10.15% from its current price of $255.68.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $231.00 representing 100% downside risk from its current price of $255.68.
Fair Value
-
According to the consensus of 5 analysts, STERIS Plc (Ireland) has 10.15% upside to fair value with a price target of $281.63 per share.
STE vs. S&P 500
-
Over the past 5 trading days, STERIS Plc (Ireland) has overperformed the S&P 500 by 0.16% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
STERIS Plc (Ireland) does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
STERIS Plc (Ireland) has grown year-over-year revenues for 21 quarters straight. In the most recent quarter STERIS Plc (Ireland) reported revenues of $1.5B.
Earnings Growth
-
STERIS Plc (Ireland) has grown year-over-year earnings for 6 quarters straight. In the most recent quarter STERIS Plc (Ireland) reported earnings per share of $1.94.
Enterprise value:
26.8B
EV / Invested capital:
2.96x
Price / LTM sales:
4.43x
EV / EBIT:
25.32x
EV / Revenue:
4.71x
PEG ratio (5yr expected):
0.60x
EV / Free cash flow:
28.00x
Price / Operating cash flow:
26.35x
Enterprise value / EBITDA:
17.32x
Gross Profit (TTM):
$2.5B
Return On Assets:
6.74%
Net Income Margin (TTM):
12.11%
Return On Equity:
10.26%
Return On Invested Capital:
7.73%
Operating Margin:
18.41%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $4.9B | $5.3B | $5.7B | $1.3B | $1.5B | |
| Gross Profit | $2.1B | $2.3B | $2.5B | $581.5M | $644.9M | |
| Operating Income | $834.3M | $944.8M | $1.1B | $225.3M | $268.9M | |
| EBITDA | $1.4B | $1.4B | $1.5B | $340.6M | $390.6M | |
| Diluted EPS | $5.52 | $4.38 | $7.03 | $1.51 | $1.94 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.9B | $1.9B | $2.2B | $1.9B | $2.1B | |
| Total Assets | $11.8B | $10.5B | $11.3B | $10.2B | $10.4B | |
| Current Liabilities | $785.7M | $872.8M | $873.1M | $805.5M | $888.9M | |
| Total Liabilities | $5.2B | $4.7B | $5.1B | $3.6B | $3.4B | |
| Total Equity | $6.5B | $5.8B | $6.2B | $6.6B | $7B | |
| Total Debt | $3.6B | $3.2B | $3.6B | $2.4B | $2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $848.6M | $1.1B | $1.3B | $250.7M | $287.8M | |
| Cash From Investing | -$848.8M | $366.5M | -$388M | -$105.4M | -$88.3M | |
| Cash From Financing | -$55.8M | -$1.5B | -$765M | -$181M | -$159.2M | |
| Free Cash Flow | $535.4M | $680.1M | $958.9M | $148.8M | $201.3M | |
STE
Sector
Market Cap
$25.1B
$28.1M
Price % of 52-Week High
95.19%
51.39%
Dividend Yield
0.94%
0%
Shareholder Yield
2.08%
-1.49%
1-Year Price Total Return
22.52%
-17.13%
Beta (5-Year)
1.011
0.518
Dividend yield:
0.94%
Annualized payout:
$2.23
Payout ratio:
32.44%
Growth streak:
14 years
Technicals
8-day SMA
Buy
Level
$253.86
200-day SMA
Buy
Level
$239.74
Bollinger Bands (100)
Buy
Level
239.38 - 257.98
Chaikin Money Flow
Buy
Level
512.2K
20-day SMA
Sell
Level
$257.58
Relative Strength Index (RSI14)
Sell
Level
49.98
ADX Line
Buy
Level
7.51
Williams %R
Neutral
Level
-60.0762
50-day SMA
Buy
Level
$253.05
MACD (12, 26)
Buy
Level
67.02
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Neutral
Level
2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.102)
Buy
CA Score
(Annual)
Level (0.6539)
Buy
Beneish M-Score
(Annual)
Level (-2.5917)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-2.1456)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
STERIS Plc engages in the provision of healthcare and life science products and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capital equipment. The Applied Sterilization Technologies segment is involved in contract sterilization and testing services for medical device and pharmaceutical manufacturers. The Dental segment offers a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. The company was founded in 1985 and is headquartered in Dublin, Ireland.
Stock Forecast FAQ
In the current month, STE has received 3 Buy ratings 2 Hold ratings, and 0 Sell ratings. The STE average analyst price target in the past 3 months is $281.63.
-
Where Will STERIS Plc (Ireland) Stock Be In 1 Year?
According to analysts, the consensus estimate is that STERIS Plc (Ireland) share price will rise to $281.63 per share over the next 12 months.
-
What Do Analysts Say About STERIS Plc (Ireland)?
Analysts are divided on their view about STERIS Plc (Ireland) share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that STERIS Plc (Ireland) is a Sell and believe this share price will drop from its current level to $231.00.
-
What Is STERIS Plc (Ireland)'s Price Target?
The price target for STERIS Plc (Ireland) over the next 1-year time period is forecast to be $281.63 according to 5 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is STE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for STERIS Plc (Ireland) is a Buy. 3 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of STE?
You can purchase shares of STERIS Plc (Ireland) via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase STERIS Plc (Ireland) shares.
-
What Is The STERIS Plc (Ireland) Share Price Today?
STERIS Plc (Ireland) was last trading at $255.45 per share. This represents the most recent stock quote for STERIS Plc (Ireland). Yesterday, STERIS Plc (Ireland) closed at $255.68 per share.
-
How To Buy STERIS Plc (Ireland) Stock Online?
In order to purchase STERIS Plc (Ireland) stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get STE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
STE
Sector
P/E ratio
36.39x
23.89x
PEG ratio
0.60x
-0.01x
P/B ratio
3.58x
1.81x
Price / LTM sales
4.43x
1.59x
Growth Metrics
STE
Sector
Revenue growth
9.89%
4.62%
Earnings growth
28.43%
11.06%
Revenue (5-year growth)
12.49%
6.5%
Earnings forecast
$2.35
-$0.21
Profitability
STE
Sector
Profitability FY 2024
$2.4B
$3.6M
Return on invested capital
7.73%
-31.84%
Return on assets
6.74%
-27.96%
Return on equity
10.26%
-37.63%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Feb
4
Balance Sheet
STE
Sector
Total cash
$319.2M
$26.4M
Short term investments
--
$25.7M
Total assets
$10.1B
$76.9M
Long term debt
$2B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
